“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

28 June 2019
Pharma

Visiongain has launched a new pharma report Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019: Branded Drugs, Generic Drugs, Leading Companies.

The pharmaceutical wholesale and distribution market is vital, providing access to life saving drugs to vast number of people in a timely manner. The market is large, with many opportunities for growth and development during the forecast period.

The establishment of the pharmaceutical wholesale market was driven by manufacturers wanting to outsource distribution to wholesalers to focus on core competencies of R&D and marketing. At the same time, hospitals outsourced inventory management in an effort to reduce investment in this area. These factors created a high demand for a comprehensive wholesale and distribution service.

The lead analyst of the report commented "Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals. Distributing increased volumes of drugs will benefit wholesalers through increased revenues. The increased sales volume will be particularly noticeable in emerging markets, such as China, India and Brazil."

Leading companies featured in the report include Alfresa Holdings, AmerisourceBergen, Anda Inc., Auburn Pharmaceutical Company, Capital Wholesale Drug Company, Cardinal Health, CR Pharmaceutical, CuraScript Special, Dakota Drug, Inc., Fff Enterprises Inc., and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Ophthalmic Drugs market set to grow to $32bn by 2024” says Visiongain report

Successful harnessing of the opportunities for growth in the ophthalmic pharmaceuticals market will depend upon the development of novel products with technologies that increase clinical effectiveness and development of products for previously-untreated ophthalmic conditions.

15 August 2019

Read

“Global Medical Device Contract Manufacturing market set to grow to $130bn by 2024” says new Visiongain report

The available reduced costs of outsourced manufacturing combined with access to the innovation power of CMOs are major drivers behind the decision to outsource manufacturing processes.

06 August 2019

Read

“3D Printing for Healthcare market is worth $872 million in 2019” says Visiongain report

The main appeal of 3D printed healthcare products to professionals is that each unit can be personalised to fit the recipient.

02 August 2019

Read

“Global Rare Disease Drugs market set to grow to $257bn by 2024” says new Visiongain report

It is difficult to investigate rare diseases as the pool of patients is very small and often results in inadequate clinical knowledge.

01 August 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever